Jean-Yves Fagon,* Jean Chastre, Yves Domart, Jean-Louis Trnuillet, and Claude Gibert
|
|
- Richard Miles
- 6 years ago
- Views:
Transcription
1 538 Mortality Due to Ventilator-Associated Pneumonia or Colonization with Pseudomonas or Acinetobacter Species: Assessment by Quantitative Culture of Samples Obtained by a Protected Specimen Brush Jean-Yves Fagon,* Jean Chastre, Yves Domart, Jean-Louis Trnuillet, and Claude Gibert From the Service de Reanimation Medicale, Hopital Bichat, Paris, France Ventilator-associated pneumonia (VAP) due to multiresistant pathogens is associated with a high death rate. We analyzed the relationship betweenvap due to Pseudomonas or Acinetobacter species and death by comparing the outcomes for patients colonizedwith these pathogens (bacterial counts of <10 3 cfu/ml) with those for patients with pneumonia due to these pathogens (bacterial counts of ~103 cfulml). Samples were obtained systematically with a protected specimen brush when pneumonia was suspected. Clinical characteristics at admission to our intensivecare unit and clinical features at the time of suspicion of VAP were not significantlydifferent between colonized patients and those with YAP. Mortality rates were 29% among colonized patients and 73% among patients with VAP (P <.001). These results demonstrate a relationship between a high mortality rate and the development of pneumonia due to multiresistant, nonfermenting, gram-negative bacilli (~103 cfu/ml) in the lower airways of patients receiving ventilatory support. Ventilator-associated pneumonia (VAP) in critically ill patients is associated with a high mortality rate [1]. However, the respective influences ofthe severity ofthe underlying disease(s) and the occurrence of pneumonia on death are difficult to assess in patients treatedwith mechanicalventilationbecause these are the most severely ill patients with the most severe nosocomial infection [2]. In other words, it is difficult to establish whether such patients would have survived if nosocomial pneumonia had not occurred. Nevertheless, nosocomial pneumonias due to nonfennenting, gram-negative bacilli and particularly those due to Pseudomonas or Acinetobacter species have repeatedly been described as being associated with the highest death rates among patients receiving ventilatory support [1, 3]. Analysis ofthe epidemiologic characteristics ofpneumonia developing in patients receiving ventilatory support has been limited by the difficulty encountered in clearly distinguishing between true bacterial pneumonia and lung processes mimicking pneumonia that are or are not associated with colonization ofthe lower airways [4, 5]. The technique ofobtaining uncontaminated lower-airway secretions for quantitative cultures with use ofa protected specimen brush (PSB) during fiberoptic bronchoscopy was introduced by Wimberley et a1. [6]; this technique is considered to be one ofthe more appropriate tools for identifying pneumonia in patients undergoing mechanical ventilation or at least for differentiating between patients with Received 22 November 1995; revised 8 May *Current affiliation: Service de Reanimation Medicale, H6pital Broussais, Paris, France. Reprints or correspondence: Dr. Jean-Yves Fagon, Service de Reanimation Medicale, Hopital Bichat, 46 rue Henri-Huchard, Paris Cedex 18, France. Clinical Infectious Diseases 1996;23: by The University of Chicago. All rights reserved /96/ $02.00 high distal bacterial counts (~10 3 cfu/ml) who are considered to have true pneumonia and those with low distal bacterial counts (< 10 3 cfulml) who are considered to have simple colonization of the lower airways [4-7]. Indeed, the ability to make such a distinction is one of the ways of recognizing the specific epidemiologic characteristics of VAP in a comparison of VAP with ventilator-associated colonization of the lower airways. The aim of this study was to compare the clinical characteristics of and the outcomes for two groups ofpatients receiving ventilatory support who were suspectedofhaving pneumoniaon clinical grounds; pneumonia (bacterial counts of ~ 10 3 cfu/ml) or colonization (bacterial counts of < 10 3 cfulml) due to Pseudomonas or Acinetobacter species was diagnosed for these patients on the basis of the results ofquantitative cultures ofsamples obtained a with PSB. Methods Patient Selection Over a 5-year period, the results of quantitative cultures of PSB samples that demonstrated the presence of Pseudomonas or Acinetobacter species were used to identify two groups of patients receiving ventilatory support: patients with pneumonia due to these pathogens who had bacterial counts of ~ 10 3 cfulml and patients whose lower respiratory tract was merely colonized by these nonfermenting, gram-negative bacilli and who had bacterial counts of < 10 3 cfulml, even if > 10 3 cfu of another potential pathogenlml grew. During the study period, PSB samples were obtained from every patient suspected of having VAP. The clinical suspicion of VAP was based on the presence of a new, persistent lung infiltrate on chest roentgenograms, macroscopically purulent tracheal aspirates, and mechanical ventilation for >48 hours. Fiberoptic broncho-
2 em 1996;23 (September) Mortality Due to VAP with Pseudomonas or Acinetobacter 539 scopic examination and PSB sampling were performed following a protocol previously described in detail [7]. Patients identified as having pneumonia were treated with antimicrobial agents effective against the isolated Pseudomonas or Acinetobacter species. No new therapy with antibiotics effective against these bacilli was given to patients colonized by these microorganisms. For the purpose ofthe present study, patients from whom Pseudomonas or Acinetobacter species were isolated at low concentrations «10 3 cfulml) in association with significant concentrations (~10 3 cfulml) of other pathogens were classified as being colonized with Pseudomonas or Acinetobacter species. They were treated with antimicrobial agents effective against pathogens cultured at counts of ;=:10 3 cfulml. Death in the intensive care unit (lcu) was used as the unique endpoint. Data Collection The following data were recorded at the time of admission to our ICU: age; sex; location prior to admission; severity of underlying medical conditions stratified according to the criteria of McCabe and Jackson [8] as fatal, ultimately fatal, or nonfatal; indication for ventilatory support based on the classification ofzwillich and co-workers [9]; simplified acute physiology score [10]; and presence or absence of infection and/or organ system (respiratory, cardiac, renal, hepatic, neurological, and/or hematologic) failure(s), definitions of which have been previously described [11]. In addition, the following clinical features were noted on the day that VAP was clinically suspected: duration ofmechanical ventilation; use of prior antimicrobial therapy; presence or absence of any of the six organ system failures cited above; temperature; WBC count; arterial oxygen pressure (Pao2)/ inspired oxygen fraction (Fio-) ratio; radiological score determined by a technique previously described [1]; and changes in temperature, WBC count, and Paoj/f'io, ratio during the 3 days preceding bronchoscopy. Statistical Analysis Patient characteristics are expressed as means ± SD or as the number of patients. Comparisons were made with use of the Student's z-test or analysis of variance for continuous variables and the X 2 statistic for categorical variables; P values of <.05 were considered statistically significant. Results Of 941 patients who received ventilatory support for >48 hours, 60 (6.4%) had pneumonia due to Pseudomonas species (45) or Acinetobacter species (15) (bacterial counts of ~ 10 3 cfu/ml), and 48 (5.1%) were colonized with Pseudomonas species (31) or Acinetobacter species (17) (bacterial counts of < 10 3 cfu/ml). Another organism (Streptococcus species, 2; Table 1. Characteristics ofpatients with pneumonia or colonization with Pseudomonas or Acinetobacter species at admission to an rcu. Value Pneumonia Colonization Parameter (n = 60) (n = 48) Mean age (y) ± SD 63 ± II 60 ± 12 No. (%) of males 45 (75) 38 (79) No. (%) admitted from Community 9 (15) 11 (23) Wards 19 (32) 12 (25) Another ICU 32 (53) 25 (52) No. (%) with severity of underlying disease Absence 3 (5) 7 (15) Nonfatal 48 (80) 25 (52) Ultimately or rapidly fatal 9 (15) 16 (33) No. (%) with indication for ventilatory support Chronic airway obstruction 9 (15) 6 (13) Other pulmonary disease 8 (13) 8 (17) Postoperative respiratory failure 31 (52) 22 (46) Drug overdose 0 3 (6) Neurological emergency 8 (13) 3 (6) Miscellaneous 4 (7) 6 (13) SAPS ± SD 12.1 ~ ~ 4.2 No. (%) with organ failure Respiratory 60 (100) 48 (100) Cardiovascular 28 (47) 25 (52) Neurological 18 (30) 18 (38) Renal 15 (25) 7 (15) Hepatic 7 (12) 3 (6) Hematologic 3 (5) 4 (8) Mean total number of organs affected ± SD 2.2 ± ::t: 1.2 NOTE. No differences between groups were significant. ICU = intensive care unit; SAPS = simplified acute physiology score. Branhamella catarrhalis, 2; Haemophilus infiuenzae, 1; and methicillin-sensitive Staphylococcus aureus, I) was simultaneously isolated at a significant concentration from six of 48 colonized patients. Pneumonia due to S. aureus, Legionella pneumophila, and Escherichia coli subsequently developed in three patients; these cases were diagnosed by conventional cultures yielding ~ 10 3 cfu/ml or buffer charcoal yeast extract (BCYE) cultures. According to the results of antibiotype and biotype determinations, no clustering of cases of nosocomial infections due to Pseudomonas or Acinetobacter species was observed in the ICU during the study period. The results ofa comparison ofthe characteristics ofinfected and colonized patients are shown in table 1; no significant differences concerning location before ICU admission, preexisting extensive functional disability, major comorbidities, acute physiological abnormalities, and age were found. Moreover, as indicated in table 2, patients with pneumonia did not differ clinically from patients with colonization at the time that they were suspected of having pneumonia; this difference was evaluated by temperature, WBC count, Pao2IFio2 ratio, radiological score, presence of organ
3 540 Fagon et al. ern 1996;23 (September) Table 2. Clinical features at the time ofclinical suspicion ofpneumonia in patients with pneumonia or colonization with Pseudomonas or Acinetobacter species. Value Parameter Pneumonia(n = 60) Colonization(n = 48) Mean duration (d) of mechanicalventilation ± SD No. (%) with prior antimicrobial therapy Mean temperature (0C) ± SD Mean WBC count (from 3 ) ± SD Mean PaozlFioz ratio (rom Hg) ± SD Mean radiological score* ± SD No. (%) with organ failure Respiratory Cardiovascular Neurological Renal Hepatic Hematologic Mean total number of organs affected ± SD Change" in Mean temperature ec) ± SD Mean PaozlFioz ratio (rom Hg) ± SD Mean WBC count (zmrrr') ± SD 12 ± (78) 38.6 ± ,300 ± 7, ± ± (100) 19 (32) 22 (37) 13 (22) 6 (10) 5 (8) 2.1 ± ± 0.9 ~0.7 ± 80 +2,400 ± 8, ± (69) 38.2 ± ,600 ± 9, ± ± (100) 14 (29) 8 (17) 9 (19) 2 (4) 2 (4) 1.7 ± ± ± ± 6,800 NOTE. No differences between groups were significant. All values were noted at the time of bronchoscopy. PaozlFioz = arterial oxygen pressure/inspired oxygen fraction. * Determinedby a previously described technique [1]. t Changes in temperature, Paoj/Fio, ratio, and WBC count are differencesbetween values at the time ofbronchoscopy and values on the third day before bronchoscopy. failure, and changes in temperature, WBC count, or PaoiFio 2 ratio during the 3 days preceding bronchoscopy as well as by prior antimicrobial therapy (including the number of patients who received therapy with potentially effective antibiotics against Pseudomonas and Acinetobacter species). The mortality rate among patients with pneumonia was 73%, compared with 29% among patients colonized with Pseudomonas or Acinetobacter species (P <.00I); the colonized patients who died included three (50%) of the six patients with pneumonia due to another pathogen. The mortality rate among patients with pseudomonas pneumonia was 73%, and the mortality rate among patients with acinetobacter pneumonia was 73%; the mortality rates among colonized patients were 29% and 29%, respectively (NS). The results of an analysis of mortality as a function of the findings of quantitative cultures of PSB samples are shown in figure 1. Death occurred in 12 of 18, 12 of 14, 12 of 15, and 8 of 13 patients with pneumonia who had bacterial counts in the ranges < 10 4, 10 4 _< 10 5, < 10 6, and ~ 10 6 cfu/ml, respectively (NS). One of 12 colonized patients whose bacterial counts were < 10 2 cfu/ml and 13 of 36 colonized patients with bacterial counts between 10 2 and < 10 3 cfu/ml died (P =.08). Thirty-five ofthe colonized patients were not treated with antibiotics effective against Pseudomonas or Acinetobacter species during the follow-up period. In fact, 13 ofthe 48 colonized patients were receiving therapy with antibiotics potentially active against these nonfermenting, gram-negative bacilli during their ICU stay for treatment of an extrapulmonary infection; no difference in their mortality rate was observed (data not shown). During the study period, 240 (28.8%) ofthe 833 patients who received ventilatory support for >48 hours and did not have pneumonia or colonization with these pathogens died. Discussion This study of patients who received ventilatory support for >48 hours in a medical ICU and were clinically suspected of :! cgi 'OJ III 20 Q. '0 ci z 10 O~-_----J Figure % 66.6% Bacterial counts (cfu/ml) Mortality rates (percentages given above the columns) among patients with pneumonia or colonization with Pseudomonas or Acinetobacter species; the rates are based on the results ofquantitative cultures of samples obtained by a protected specimen brush. Open bars = survivors; solid bars = nonsurvivors.
4 em 1996;23 (September) Mortality Due to VAP with Pseudomonas or Acinetobacter 541 having YAP because ofthe presence ofanew lung infiltrate and purulent tracheal secretions demonstrated that bacteriologically proven VAP due to Pseudomonas or Acinetobacter species was associated with a higher mortality rate than colonization of the lower airways with these pathogens; pneumonia or colonization was determined on the basis of the results of quantitative cultures of PSB samples. These cultures were used to differentiate between true lung infection and distal airway colonization. The technique of obtaining samples with a PSB for quantitative cultures is a diagnostic method that was introduced by Wimberley and associates [6] in 1979 and has been extensively evaluated for 15 years. The results of these evaluations, which have been reported in terms of diagnostic accuracy, vary widely, depending on the reference technique used, the previous use of antimicrobial agents, the experience of the evaluators, and the quality of the bacteriologic processing. However, although some controversy exists concerning the sensitivity of the technique of obtaining PSB samples [12, 13], there is a consensus that considers this technique to be highly specific with low rates of false-positive results. A quantitative culture yielding> 10 3 cfu/ml has been demonstrated in experimental studies and subsequently has been clinically accepted as the most accurate diagnostic threshold for identifying lower respiratory tract infection. Such a bacterial count reflects about 10 6 bacteria/ml of respiratory secretions at the site of infection since the volume of the secretions collected with the brush is ml [14]. Recently, Dreyfuss and colleagues [15] suggested that treating all patients with borderline bacterial counts, ranging from ~ 10 2 to < 10 3 cfujml, would lead to overtreatment in most cases. These authors suggested that colonization of the lower respiratory tract in patients receiving ventilatory support is probably a dynamic process that can lead to either bacterial clearing or proliferation, with the development of pneumonia depending on the ability of the host to eradicate the microorganism. In our study, PSB samples were repeatedly obtained from patients who were persistently clinically suspected of having VAP; these patients were classifiedin the pneumonia group since at least one quantitativeculture of a PSB sample yielded Pseudomonas or Acinetobacter speciesat a significantconcentration. Consequently, the presence of false-negative results (i.e., patients with pneumonia who were not included in the study because of a sterile culture of a PSB sample or who were wrongly includedin the colonization group because of a bacterial count of < 10 3 cfu/ml) was highly improbable even if such results could occur particularlyin patients who received prior antimicrobial therapy. Moreover, because of the overall diagnostic accuracy and especially the high specificityof the technique of obtaining PSB samples, the probability that patients classified as having pneumonia (based on the results of quantitative cultures of PSB samples) effectively did not have pneumonia is very low. Whatever the limitations concerning the use of PSB samples for diagnosing VAP, our study suggests at least that low bacterial counts were associated with low mortality rates. Pneumonia due to Pseudomonas or Acinetobacter species is usually associated with a high mortality rate; this rate is frequently > 70% and is significantly higher than those among patients with pneumonia due to other microorganisms [1, 3, 16]. In our study, the mortality rate among patients with bacteriologically confirmed pneumonia due to Pseudomonas and Acinetobacter species was 73%; this rate was significantly higher than that among patients with the same clinical condition at admission who received ventilatory support for the same duration and were clinically indistinguishable from patients with clinical signs of pneumonia who did not have bacteriologically proven pneumonia. This finding further confirms the prognostic role of nosocomial lung infection by itself in severely ill patients that was suggested in two case-control studies [17, 18]; these studies showed that the mortality directly attributable to nosocomial pneumonia was significant. Similarly, our results demonstrated no significant difference between mortality rates among colonized patients and patients who received ventilatory support for >48 hours and did not have pneumonia or colonization with Pseudomonas or Acinetobacter species (29.1 % vs. 28.8%, respectively; NS); the fact that no difference was demonstrated suggests that such patients were actually free of lung infection or at least that their bacterial counts were so low that they were not associated with mortality other than that due to the underlying conditions. Nevertheless, before such a conclusion can be accepted, two points merit emphasis. First, every time pneumonia was clinically suspected, the patient was closely monitored, and PSB samples were obtained; the patient was classified on the basis of the results of quantitative cultures of PSB samples for only Pseudomonas and Acinetobacter species. Nine patients classified as being colonized actually had pneumonia due to pathogens other than these nonfermenting, gramnegative bacilli; pneumonia was diagnosed simultaneously for six of these patients, and pneumonia subsequently developed in three. These nine patients were treated with antibiotic agents effective against the responsible pathogens. Second, patients with pneumonia were given therapy with antimicrobial agents effective against the responsible pathogens, whereas no antibiotic therapy was prescribed for colonized patients. In addition, the clinical characteristics ofpatients with bacteriologically confirmed pneumonia were not significantly different from those of colonized patients; therefore, this study indirectly confirmed the previously reported difficulty encountered in clinically distinguishing between pneumonia and colonization in patients receiving ventilatory support in the absence of a reliable diagnostic technique [4, 5, 12, 13]. In conclusion, our results suggest that pseudomonas or acinetobacter VAP determined on the basis of stringent bacteriologic criteria is, at least partially, responsible by itself for a mortality rate higher than that among colonized patients receiving mechanical ventilation.
5 542 Fagon et al. ern 1996;23 (September) Acknowledgment The authors thank Mrs. C. Brun for preparing the manuscript. References 1. Fagon J-Y, Chastre J, Domart Y, et al. Nosocomial pneumonia in patients receiving continuousmechanical ventilation: prospective analysis of 52 episodeswith use of a protected specimenbrush and quantitativeculture techniques. Am Rev Respir Dis 1989;139: Craven DE, Kunches LM, KilinskyV, LichtenbergDA, Make BJ, McCabe WR. Risk factors for pneumoniaand fatalityin patientsreceivingcontinuous mechanical ventilation. Am Rev Respir Dis 1986;133: Stevens RM, Teres D, Skillman JJ, Feingold DS. Pneumonia in an intensive care unit: a 30-monthexperience. Arch Intern Med 1974;134: Meduri GU. Ventilator-associatedpneumonia in patients with respiratory failure: a diagnostic approach. Chest 1990;97: Fagon J-Y, Chastre J, Hance AJ, Domart Y, Trouillet J-L, Gilbert C. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest 1993;103: WimberleyN, Faling LJ, Bartlett JG. A fiberopticbronchoscopytechnique to obtain uncontaminated lower airway secretions for bacterial culture. Am Rev Respir Dis 1979;119: Chastre J, Fagon J-Y, Soler P, et al. Diagnosis of nosocomial bacterial pneumonia in intubated patients undergoing ventilation: comparison of the usefulness of bronchoalveolar lavage and the protected specimen brush. Am J Med 1988;85: McCabe WR, Jackson GG. Gram-negative bacteremia. I. Etiology and ecology. Arch Intern Med 1962;110: Zwillich CW, Pierson DJ, Creagh CE, Sutton FD, Schatz E, Petty TL. Complicationsof assistedventilation:a prospectivestudyof 354 consecutive episodes. Am J Med 1974;57: Le Gall J-R, Loirat P, AlperovitchA, et al. A simplifiedacute physiology score for ICU patients. Crit Care Med 1984;12: II. Fagon JY, Chastre J, Novara A, Medioni P, Gibert C. Characterization of intensive care unit patients using a model based on the presence or absence of organ dysfunctionsand/or infection: the ODIN model. Intensive Care Med 1993;19: Niederman MS, Torres A, Summer W. Invasive diagnostic testing is not needed routinelyto manage suspected ventilator-associatedpneumonia. Am J Respir Crit Care Med 1994;150: Chastre J, Fagon JY. Invasivediagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia. Am J Respir Crit Care Med 1994;150: Bartlett JG, Finegold SM. Bacteriology of expectorated sputum with quantitativeculture and wash technique compared to transtrachealaspirates. Am Rev Respir Dis 1978;117: Dreyfuss D, Mier L, Le Bourdelles G, et al. Clinical significance of borderline quantitative protected brush specimen culture results. Am Rev Respir Dis 1993;147: Bryan CS, ReynoldsKL. Bacteremic nosocomialpneumonia: analysis of 172 episodes from a single metropolitanarea. Am Rev Respir Dis 1984; 129: CraigCP, ConnellyS. Effect of intensivecare unit nosocomialpneumonia on duration of stay and mortality. Am J Infect Control 1984;12: Fagon J-Y, Chastre J, Hance AJ, Montravers P, Novara A, Gibert C. Nosocomialpneumoniain ventilatedpatients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 1993;94:281-8.
CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement
CHEST VOLUME 117 / NUMBER 4 / APRIL, 2000 Supplement Evidence-Based Assessment of Diagnostic Tests for Ventilator- Associated Pneumonia* Executive Summary Ronald F. Grossman, MD, FCCP; and Alan Fein, MD,
More informationANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationDiagnosis of Ventilator- Associated Pneumonia: Where are we now?
Diagnosis of Ventilator- Associated Pneumonia: Where are we now? Gary French Guy s & St. Thomas Hospital & King s College, London BSAC Guideline 2008 Masterton R, Galloway A, French G, Street M, Armstrong
More informationEvaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa
973 Evaluation of Outcome for Intubated Patients with Pneumonia Due to Pseudomonas aeruginosa Jordi Rello, Paola Jubert, Jordi Valles, Antonio Artigas, Montse Rue, and Michael S. Niederman From the Department
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationThe Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia
The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia JORDI RELLO, MIGUEL GALLEGO, DOLORS MARISCAL, ROSARIO SOÑORA, and JORDI VALLES Intensive Care, Respiratory and Microbiology
More informationImpact of humidification and gas warming systems on ventilatorassociated
Online Data Supplement Impact of humidification and gas warming systems on ventilatorassociated pneumonia. Jean-Claude Lacherade, M.D. 1, Marc Auburtin, M.D. 2, Charles Cerf, M.D. 3, Andry Van de Louw,
More informationHospital Acquired Pneumonias
Hospital Acquired Pneumonias Hospital Acquired Pneumonia ( HAP ) Hospital acquired pneumonia ( HAP ) is defined as an infection of the lung parenchyma developing during hospitalization and not present
More informationDiagnosis of Lower Respiratory Tract Infections* What We Have and What Would Be Nice. Robert P. Baughman, MD, FCCP; and Chiara E.
Diagnosis of Lower Respiratory Tract Infections* What We Have and What Would Be Nice Robert P. Baughman, MD, FCCP; and Chiara E. Conrado, MD Study objectives: To review the various methods used to diagnose
More informationPREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP) PATIENTS OF INTENSIVE CARE UNIT (ICU) IN MAHARASHTRA REGION.
Original research article International Journal of Medical Science and Education pissn- 2348 4438 eissn-2349-3208 PREVALENCE PATTERN OF MORBIDITY AND MORTALITY IN VENTILATION ASSOCIATED PNEUMONIA (VAP)
More informationISF criteria (International sepsis forum consensus conference of infection in the ICU) Secondary peritonitis
Appendix with supplementary material. This appendix was part of the submitted manuscript and has been peer reviewed. It is posted as supplied by the authors. Supplementary Tables Table S1. Definitions
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationVentilator Associated
Ventilator Associated Pneumonia: Key and Controversial Issues Christopher P. Michetti, MD, FACS Inova Fairfax Hospital, Falls Church, VA Forrest Dell Moore, MD, FACS Banner Healthcare System, Phoenix,
More informationVentilator Associated Pneumonia. ICU Fellowship Training Radboudumc
Ventilator Associated Pneumonia ICU Fellowship Training Radboudumc Attributable mortality VAP Meta-analysis of individual patient data from randomized prevention studies Attributable mortality mainly results
More informationDiagnosing Pneumonia during Mechanical Ventilation The Clinical Pulmonary Infection Score Revisited
Diagnosing Pneumonia during Mechanical Ventilation The Clinical Pulmonary Infection Score Revisited Muriel Fartoukh, Bernard Maître, Stéphanie Honoré, Charles Cerf, Jean-Ralph Zahar, and Christian Brun-Buisson
More informationTrial protocol - NIVAS Study
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Trial protocol - NIVAS Study METHODS Study oversight The Non-Invasive Ventilation after Abdominal Surgery
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION
HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical
More informationBacteriological profile and outcome of Ventilator associated pneumonia in Intensive care unit of a tertiary care centre
ORIGINAL ARTICLE ASIAN JOURNAL OF MEDICAL SCIENCES Bacteriological profile and outcome of Ventilator associated pneumonia in Intensive care unit of a tertiary care centre Ravi K 1, Maithili TM 2, David
More information한국학술정보. Clinical Investigation of Pneumonia Complicating Organophosphate Insecticide Poisoning: Is It Really Aspiration Pneumonia?
Clinical Investigation of Pneumonia Complicating Organophosphate Insecticide Poisoning: Is It Really Aspiration Pneumonia? Seung Cheol Han, M.D., Young Ho Ko, M.D., Kyoung Woon Jung, M.D., Tag Heo, M.D.,
More informationAbstract. Introduction
ORIGINAL ARTICLE INFECTIOUS DISEASES Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care
More informationGram staining of protected pulmonary specimens in the early diagnosis of ventilator-associated pneumonia
British Journal of Anaesthesia 85 (5): 735±9 (2000) Gram staining of protected pulmonary specimens in the early diagnosis of ventilator-associated pneumonia O. Mimoz *, A. Karim, J. X. Mazoit, A. Edouard,
More informationDiagnostic accuracy of protected catheter sampling in ventilator-associated bacterial
Eur Respir J 2000; 16: 969±975 Printed in UK ± all rights reserved Copyright #ERS Journals Ltd 2000 European Respiratory Journal ISSN 09031936 Diagnostic accuracy of protected catheter sampling in ventilatorassociated
More informationClinical Practice Management Guideline for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention
Clinical for Ventilator-Associated Pneumonia: Diagnosis, Treatment & Prevention Background Ventilator-associated pneumonia (VAP), a pneumonia that develops 48hrs after initiation of mechanical ventilation,
More informationAerosolized Antibiotics in Mechanically Ventilated Patients
Aerosolized Antibiotics in Mechanically Ventilated Patients Gerald C Smaldone MD PhD Introduction Topical Delivery of Antibiotics to the Lung Tracheobronchitis Aerosolized Antibiotic Delivery in the Medical
More informationComparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults JAMA. 2003;290:
CARING FOR THE CRITICALLY ILL PATIENT Comparison of 8 vs 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults A Randomized Trial Jean Chastre, MD Michel Wolff, MD Jean-Yves Fagon,
More informationSoshi Hashimoto 1 and Nobuaki Shime 1,2*
Hashimoto and Shime Journal of Intensive Care 2013, 1:2 RESEARCH Open Access Evaluation of semi-quantitative scoring of Gram staining or semi-quantitative culture for the diagnosis of ventilator-associated
More informationEpidemiological and Microbiological Analysis of Ventilator-Associated Pneumonia Patients in a Public Teaching Hospital
482 BJID 2007; 11 (October) Epidemiological and Microbiological Analysis of Ventilator-Associated Pneumonia Patients in a Public Teaching Hospital João Manoel da Silva Júnior 1, Ederlon Rezende 1, Thaís
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationThis article examines the utility of quantitative and
Are Quantitative Cultures Useful in the Diagnosis of Hospital-Acquired Pneumonia?* Gerry San Pedro, MD Noninvasive and invasive tests have been developed and studied for their utility in diagnosing and
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationCritical Care Nursing Theory. Pneumonia. - Pneumonia is an acute infection of the pulmonary parenchyma
- is an acute infection of the pulmonary parenchyma - is a common infection encountered by critical care nurses when it complicates the course of a serious illness or leads to acute respiratory distress.
More informationto the initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report
CONSENSUS CONFERENCE Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report LIONEL A MANDELL, THOMAS J MARRIE, MICHAELS NIEDERMAN, THE CANADIAN HOSPITAL ACQUIRED
More informationPneumonia Severity Scores:
Pneumonia Severity Scores: Are they Accurate Predictors of Mortality? JILL McEWEN, MD FRCPC Clinical Professor Department of Emergency Medicine University of British Columbia Vancouver, BC Canada President,
More informationInitial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report
CONSENSUS CONFERENCE Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report T HE C ANADIAN HOSPITAL ACQUIRED PNEUMONIA CONSENSUS CONFERENCE G ROU P N OSOCOMIAL OR
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationThe Importance of Appropriate Treatment of Chronic Bronchitis
...CLINICIAN INTERVIEW... The Importance of Appropriate Treatment of Chronic Bronchitis An interview with Antonio Anzueto, MD, Associate Professor of Medicine, University of Texas Health Science Center,
More informationPneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention. Basics of Infection Prevention 2-Day Mini-Course 2016
Pneumonia (PNEU) and Ventilator-Associated Pneumonia (VAP) Prevention Basics of Infection Prevention 2-Day Mini-Course 2016 Objectives Differentiate long term care categories of respiratory infections
More informationJean Chastre, Jean-Louis Trouillet, Alain Combes, and Charles-Edouard Luyt
SUPPLEMENT ARTICLE Diagnostic Techniques and Procedures for Establishing the Microbial Etiology of Ventilator- Associated Pneumonia for Clinical Trials: The Pros for Quantitative Cultures Jean Chastre,
More informationNosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria
Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000
More informationVentilator-Associated Pneumonia: Diagnosis, Treatment, and Prevention
CLINICAL MICROBIOLOGY REVIEWS, Oct. 2006, p. 637 657 Vol. 19, No. 4 0893-8512/06/$08.00 0 doi:10.1128/cmr.00051-05 Copyright 2006, American Society for Microbiology. All Rights Reserved. Ventilator-Associated
More informationinfection control and hospital epidemiology january 2008, vol. 29, no. 1 original article
infection control and hospital epidemiology january 2008, vol. 29, no. 1 original article Development of an Algorithm for Surveillance of Ventilator-Associated Pneumonia With Electronic Data and Comparison
More informationThe Attributable Morbidity and Mortality of Ventilator-Associated Pneumonia in the Critically Ill Patient
The Attributable Morbidity and Mortality of Ventilator-Associated Pneumonia in the Critically Ill Patient DAREN K. HEYLAND, DEBORAH J. COOK, LAUREN GRIFFITH, SEAN P. KEENAN, and CHRISTIAN BRUN-BUISSON
More informationSupplementary Online Content
Supplementary Online Content Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory
More informationTHE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA.
THE MICROBIOLOGICAL PROFILE OF VENTILATOR ASSOCIATED PNEUMONIA. Dr. Poonam C. Sharma, Dr. S. S. Raut, Dr. S. R. More, Dr. V. S. Rathod, Dr. V. M. Gujar. 1. Post Graduate Student, Department of Microbiology,
More informationEUROANESTHESIA 2007 Munich, Germany, 9-12 June RC4
POSTOPERATIVE PNEUMONIA EUROANESTHESIA 2007 Munich, Germany, 9-12 June 2007 12RC4 HERVÉ DUPONT Anaesthesiology and Intensive Care Medicine North University Hospital Amiens, France Saturday Jun 9, 2007
More informationNOSOCOMIAL pneumonia (NP) is the second. Nosocomial Pneumonia in a Pediatric Intensive Care Unit
Nosocomial Pneumonia in a Pediatric Intensive Care Unit P.K. Patra, M. Jayashree, S. Singhi, P. Ray* and A.K. Saxena** From the Departments of Pediatrics, Microbiology* and Radiodiagnosis** Postgraduate
More informationCross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit
Thorax 1998;53:1053 1058 1053 Internal Medicine, University Hospital Maastricht, Maastricht, The DCJJBergmans S van der Geest R M Wilting P W de Leeuw Internal Medicine, University Hospital Utrecht, Utrecht,
More informationClinialTrials.gov Identifier: sanofi-aventis. Sponsor/company: 07/November/2008
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinialTrials.gov
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationB. Barreiro*, J. Dorca*, L. Esteban*, E. Prats*, J.M. Escribá**, R. Verdaguer +, F. Gudiol ++, F. Manresa*
Eur Respir J, 1995, 8, 1543 1547 DOI: 10.1183/09031936.95.08091543 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1995 European Respiratory Journal ISSN 0903-1936 Risk factors for the development
More informationUsefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated pneumonia in extremely preterm neonates
(2010) 30, 270 274 r 2010 Nature Publishing Group All rights reserved. 0743-8346/10 $32 www.nature.com/jp ORIGINAL ARTICLE Usefulness of Gram staining of tracheal aspirates in initial therapy for ventilator-associated
More informationPradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD; Julie Hughes, RGN; and Rick van Saene, MD
Topical Antibiotics on Tracheostoma Prevents Exogenous Colonization and Infection of Lower Airways in Children* Pradeep Morar, MD; Zvoru Makura, MD; Andrew Jones, MD; Paul Baines, MD; Andrew Selby, MD;
More informationThe clinical implication and prognostic predictors of Tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii
Journal of Infection (2011) 63, 351e361 The clinical implication and prognostic predictors of Tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii R 陳南丞 VS 余文良醫師 本檔僅供內部教學使用檔案內所使用之照片之版權仍屬於原期刊公開使用時,
More informationSupplementary Online Content
Supplementary Online Content Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova N. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. doi:10.1001/jama.2017.4287
More informationManagement of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures
ORIGINAL ARTICLE 10.1111/j.1469-0691.2008.02649.x Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures B. Herer 1,2, C. Fuhrman 2, Z. Gazevic
More informationRoutine endotracheal cultures for the prediction of sepsis in ventilated babies
Archives of Disease in Childhood, 1989, 64, 34-38 Routine endotracheal cultures for the prediction of sepsis in ventilated babies T A SLAGLE, E M BIFANO, J W WOLF, AND S J GROSS Department of Pediatrics,
More informationPseudomonas aeruginosa
JOURNAL OF CLINICAL MICROBIOLOGY, July 1983, p. 16-164 95-1137/83/716-5$2./ Copyright C) 1983, American Society for Microbiology Vol. 18, No. 1 A Three-Year Study of Nosocomial Infections Associated with
More informationEnterobacter aerogenes
Enterobacter aerogenes Piagnerelli M 1, Carlier E 1, Deplano A 3, Lejeune P 1, Govaerts D 2 1 Departments of Intensive Care and 2 Microbiology, A. Vésale Hospital. 6110 Montigny-le-Tilleul. 3 Department
More informationNonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns
The Turkish Journal of Pediatrics 2006; 48: 213-220 Original Nonbronchoscopic bronchoalveolar lavage for diagnosing ventilator-associated pneumonia in newborns Nilgün Köksal 1, Mustafa Hacımustafaoğlu
More informationThe diagnosis and treatment of ventilator-associated
Invasive and Noninvasive Strategies for Management of Suspected Ventilator-Associated Pneumonia A Randomized Trial Jean-Yves Fagon, MD; Jean Chastre, MD; Michel Wolff, MD; Claude Gervais, MD; Sylvie Parer-Aubas,
More informationWork-up of Respiratory Specimens Now you can breathe easier
34 th Annual Meeting Southwestern Association of Clinical Microbiology Work-up of Respiratory Specimens Now you can breathe easier Yvette S. McCarter, PhD, D(ABMM) Director, Clinical Microbiology Laboratory
More informationResearch & Reviews of. Pneumonia
Chapter Clinical Presentation and Diagnosis of VAP in Adult ICU Patients Priyam Batra * ; Purva Mathur Research & Reviews of Department of Laboratory Medicine, AIIMS, Trauma Centre, New Delhi, India. *
More informationEpidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell
LOWER RESPIRATORY TRACT INFECTIONS Preface Thomas M. File, Jr xiii Community-Acquired Pneumonia: Pathophysiology and Host Factors with Focus on Possible New Approaches to Management of Lower Respiratory
More informationPERCUTANEOUS DILATATIONAL TRACHEOSTOMY
PERCUTANEOUS DILATATIONAL TRACHEOSTOMY GM KOKSAL *, NC SAYILGAN * AND H OZ ** Abstract Background: The aim of this study was to investigate the rate, timing, the incidence of complications of percutaneous
More informationOriginal Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1
Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), 195-202 Investigation on hospital-acquired pneumonia and the association between hospital-acquired pneumonia and chronic comorbidity at the Department
More informationOnline Supplement for:
Online Supplement for: INFLUENCE OF COMBINED INTRAVENOUS AND TOPICAL ANTIBIOTIC PROPHYLAXIS ON THE INCIDENCE OF INFECTIONS, ORGAN DYSFUNCTIONS, AND MORTALITY IN CRITICALLY ILL SURGICAL PATIENTS A PROSPECTIVE,
More informationAntibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract infections in adults
International Journal of Infectious Diseases (2005) 9, 274 279 http://intl.elsevierhealth.com/journals/ijid Antibiotic treatment and the diagnosis of Streptococcus pneumoniae in lower respiratory tract
More informationA Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU*
CHEST Original Research A Comparative Study of Community-Acquired Pneumonia Patients Admitted to the Ward and the ICU* Marcos I. Restrepo, MD, MSc, FCCP; Eric M. Mortensen, MD, MSc; Jose A. Velez, MD;
More informationKey words: acute respiratory failure; bronchoscopy; hypoxemia; noninvasive positive pressure ventilation; pneumonia
Noninvasive Positive-Pressure Ventilation vs Conventional Oxygen Supplementation in Hypoxemic Patients Undergoing Diagnostic Bronchoscopy* Massimo Antonelli, MD; Giorgio Conti, MD; Monica Rocco, MD; Andrea
More informationLâcher les VAP pour les VAC, les IVAC?...(CDC) INTRODUCTION
Lâcher les VAP pour les VAC, les IVAC?...(CDC) lila.bouadma@bch.aphp.fr INTRODUCTION VAP surveillance is needed to measure incidence and to gauge the success of prevention efforts. However, VAP diagnosis
More informationAntimicrobial Stewardship in Community Acquired Pneumonia
Antimicrobial Stewardship in Community Acquired Pneumonia Medicine Review Course 2018 Dr Lee Tau Hong Consultant Department of Infectious Diseases National Centre for Infectious Diseases Scope 1. Diagnosis
More informationBACTERIOLOGY OF POSTOPERATIVE PNEUMONIA EOLE STUDY Dupont H ICM 2003, 29,
Pneumonies: classification Pneumonies communautaires Pneumonies associées aux soins Non nosocomiales Nosocomiales Malade ventilé précoces tardives Malade non ventilé The concept of Health Care Associated
More informationCommunity Acquired Pneumonia. Abdullah Alharbi, MD, FCCP
Community Acquired Pneumonia Abdullah Alharbi, MD, FCCP A 68 y/ male presented to the ED with SOB and productive coughing for 2 days. Reports poor oral intake since onset due to nausea and intermittent
More informationBabak Valizadeh, DCLS
Laboratory Diagnosis of Bacterial Infections of the Respiratory Tract Babak Valizadeh, DCLS 1391. 02. 05 2012. 04. 25 Babak_Valizadeh@hotmail.com Biological Safety Cabinet Process specimens in biological
More informationBacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study
Eur Respir J 1997; 10: 1137 1144 DOI: 10.1183/09031936.97.10051137 Printed in UK - all rights reserved Copyright ERS Journals Ltd 1997 European Respiratory Journal ISSN 0903-1936 Bacterial colonization
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
More informationStroke-associated pneumonia: aetiology and diagnostic challenges
Stroke-associated pneumonia: aetiology and diagnostic challenges Craig J Smith Greater Manchester Comprehensive Stroke Centre, Salford Royal NHS Foundation Trust University of Manchester Smith and Tyrrell,
More informationGuidelines. 14 Nov Marc Bonten
Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.
More informationNew Surveillance Definitions for VAP
New Surveillance Definitions for VAP 2012 Critical Care Canada Forum Toronto Dr. John Muscedere Associate Professor of Medicine, Queen s University Kingston, Ontario Presenter Disclosure Dr. J. G. Muscedere
More informationPortugal. From SACiUCI to InfAUCI. Sepsis epidemiology: an update. You re only given a little spark of madness. You mustn t lose it.
Sepsis epidemiology: an update Portugal João Gonçalves Pereira ICU director Vila Franca Xira Hospital From SACiUCI to InfAUCI You re only given a little spark of madness. You mustn t lose it. Robin Williams
More informationAccurate Diagnosis Of Postoperative Pneumonia Requires Objective Data
Accurate Diagnosis Of Postoperative Pneumonia Requires Objective Data David Ebler, MD David Skarupa, MD Andrew J. Kerwin, MD, FACS Jhun de Villa, MD Michael S. Nussbaum, MD, FACS J.J. Tepas III, MD, FACS
More informationBIP Endotracheal Tube
Bactiguard Infection Protection BIP Endotracheal Tube For prevention of healthcare associated infections Ventilator associated pneumonia Infections of the respiratory tract are serious and common healthcare
More informationPrognostic factors of nosocomial pneumonia in general wards: a prospective multivariate analysis in Japan
Vol. 96 (2002) 18^23 Prognostic factors of nosocomial pneumonia in general wards: a prospective multivariate analysis in Japan Y.TAKANO, O. SAKAMOTO, M. SUGA, H. MURANAKA AND M. ANDO First Department of
More informationInfluenza-Associated Pediatric Deaths Case Report Form
STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State
More informationHospital-acquired pneumonia
Key points Hospital-acquired pneumonia has a maj impact in terms of mtality and mbidity. Empirical treatment approach is still the best course of action. Prevention is of critical imptance. REVIEW Hospital-acquired
More informationFrom the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital
From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures
More informationLower Respiratory Tract Infection
Lower Respiratory Tract Infection - Clinical Diseases and etiologic agents -Sample Collection and transport -Direct Smear (interpretation and Report) -Culture methods (interpretation and Report) The culture
More informationManagement of Acute Exacerbations
15 Management of Acute Exacerbations Cenk Kirakli Izmir Dr. Suat Seren Chest Diseases and Surgery Training Hospital Turkey 1. Introduction American Thoracic Society (ATS) and European Respiratory Society
More informationMRSA pneumonia mucus plug burden and the difficult airway
Case report Crit Care Shock (2016) 19:54-58 MRSA pneumonia mucus plug burden and the difficult airway Ann Tsung, Brian T. Wessman An 80-year-old female with a past medical history of chronic obstructive
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Blum CA, Nigro N, Briel M, et al. Adjunct prednisone
More informationAll previously published papers and figures were reproduced with permission from the publisher.
All previously published papers and figures were reproduced with permission from the publisher. Published by Karolinska Institutet. Printed by Larserics Digital Print AB. Petra Hyllienmark, 2013 ISBN ISBN
More informationInstitute of Hygiene and Environmental Medicine. Charité University Medicine Berlin. Mail:
AAC Accepts, published online ahead of print on 13 April 2009 Antimicrob. Agents Chemother. doi:10.1128/aac.01070-08 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationORIGINAL INVESTIGATION. Health Care Associated Pneumonia Requiring Hospital Admission. Epidemiology, Antibiotic Therapy, and Clinical Outcomes
ORIGINAL INVESTIGATION Health Care Associated Pneumonia Requiring Hospital Admission Epidemiology, Antibiotic Therapy, and Clinical Outcomes Jordi Carratalà, MD, PhD; Analía Mykietiuk, MD; Núria Fernández-Sabé,
More informationComparative Study of Etiological Diagnosis of Nosocomial Pneumonia
BJID 2008; 12 (February) 67 Comparative Study of Etiological Diagnosis of Nosocomial Pneumonia Eliane Maria de Carvalho 1, Paulo Celso Bosco Massarollo 2, Anna S. Levin 3, Maria Rita Montenegro Isern 4,
More informationMaking the Right Call With. Pneumonia. Community-acquired pneumonia (CAP) is a. Community-Acquired. What exactly is CAP?
Making the Right Call With Community-Acquired Pneumonia In this article: By Thomas J. Marrie, MD The case of Allyson Allyson, 32, presented to the emergency department with a 48-hour history of anorexia,
More informationThe Clinical Diagnosis of Ventilator-Associated Pneumonia
The Clinical Diagnosis of Ventilator-Associated Pneumonia Michael S Niederman MD Introduction Defining the Clinical Approach to Empiric Therapy of VAP, and Its Accuracy Methods for Clinical Diagnosis,
More information